Mireille J. Serlie

ORCID: 0000-0002-8666-3379
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diet and metabolism studies
  • Adipose Tissue and Metabolism
  • Regulation of Appetite and Obesity
  • Clinical Nutrition and Gastroenterology
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Adipokines, Inflammation, and Metabolic Diseases
  • Metabolism, Diabetes, and Cancer
  • Nutrition and Health in Aging
  • Dietary Effects on Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipid metabolism and disorders
  • Biochemical Analysis and Sensing Techniques
  • Bariatric Surgery and Outcomes
  • Eating Disorders and Behaviors
  • Neurotransmitter Receptor Influence on Behavior
  • Pharmacology and Obesity Treatment
  • Pancreatic function and diabetes
  • Abdominal Surgery and Complications
  • Diabetes Treatment and Management
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Gut microbiota and health
  • Intestinal and Peritoneal Adhesions
  • Circadian rhythm and melatonin
  • Cardiovascular Disease and Adiposity

Amsterdam University Medical Centers
2019-2025

University of Amsterdam
2015-2025

Yale University
2023-2024

Amsterdam UMC Location University of Amsterdam
2013-2023

Amsterdam Neuroscience
2020-2022

University Medical Center
2019-2020

University of New Haven
2019

Universidad de Sevilla
2018

University Medical Center Groningen
2014

University of Groningen
2014

<b><i>Introduction:</i></b> Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated a sedentary lifestyle, adipose tissue derangements, comorbidities (acute chronic diseases) during the ageing process. Co-existence excess adiposity low mass/function referred as sarcopenic (SO), condition increasingly recognized for its clinical functional features that negatively influence important...

10.1159/000521241 article EN cc-by Obesity Facts 2022-01-01

A growing body of evidence implicates ceramide and/or its glycosphingolipid metabolites in the pathogenesis insulin resistance. We have developed a highly specific small molecule inhibitor glucosylceramide synthase, an enzyme that catalyzes necessary step conversion to glycosphingolipids. In cultured 3T3-L1 adipocytes, iminosugar derivative N-(5′-adamantane-1′-yl-methoxy)-pentyl-1-deoxynojirimycin (AMP-DNM) counteracted tumor necrosis factor-α–induced abnormalities concentrations and...

10.2337/db06-1619 article EN Diabetes 2007-04-30

Bariatric surgery improves glucose metabolism. Recent data suggest that faecal microbiota transplantation (FMT) using faeces from postbariatric diet-induced obese mice in germ-free metabolism and intestinal homeostasis. We here investigated whether allogenic FMT post-Roux-en-Y gastric bypass donors (RYGB-D) compared with metabolic syndrome (METS-D) has short-term effects on metabolism, transit time adipose tissue inflammation treatment-naïve, obese, insulin-resistant male subjects.Subjects...

10.1136/gutjnl-2019-318320 article EN cc-by Gut 2019-05-30

Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated a sedentary lifestyle, adipose tissue derangements, comorbidities (acute chronic diseases), during the ageing process. Co-existence excess adiposity low mass/function referred as sarcopenic (SO), condition increasingly recognized for its clinical functional features that negatively influence important patient-centred outcomes. Effective prevention treatment...

10.1016/j.clnu.2021.11.014 article EN cc-by Clinical Nutrition 2022-02-23

Obesity is a result of relative excess in energy intake over expenditure. These processes are controlled by genetic, environmental, psychological and biological factors. One the factors involved regulation food satiety dopaminergic signalling. A small number studies have reported that striatal dopamine D2/D3 receptor [D2/3R] availability lower morbidly obese subjects.To confirm role D2/3R obesity, we measured availability, using [123I]IBZM SPECT, 15 women non-obese controls.Striatal was 23%...

10.1186/2191-219x-1-37 article EN cc-by EJNMMI Research 2011-01-01

Thyrotoxicosis increases endogenous glucose production (EGP) and induces hepatic insulin resistance. We have recently shown that these alterations can be modulated by selective sympathetic parasympathetic denervation, pointing to neurally mediated effects of thyroid hormone on metabolism. Here, we investigated the central triiodothyronine (T(3)) administration EGP. used stable isotope dilution measure EGP before after i.c.v. bolus infusion T(3) or vehicle in euthyroid rats. To study role...

10.1073/pnas.0805355106 article EN Proceedings of the National Academy of Sciences 2009-03-25

To elucidate the molecular mechanisms underlying non-alcoholic fatty liver disease (NAFLD), we recruited 86 subjects with varying degrees of hepatic steatosis (HS). We obtained experimental data on lipoprotein fluxes and used these individual measurements as personalized constraints a hepatocyte genome-scale metabolic model to investigate differences in liver, taking into account its interactions other tissues. Our systems level analysis predicted an altered demand for NAD+ glutathione (GSH)...

10.15252/msb.20167422 article EN cc-by Molecular Systems Biology 2017-03-01

Background: Gut microbiota-derived short-chain fatty acids (SCFAs) have been associated with beneficial metabolic effects. However, the direct effect of oral butyrate on parameters in humans has never studied. In this first men pilot study, we thus treated both lean and syndrome male subjects sodium investigated metabolism. Methods: Healthy males (n = 9) 10) were 4 g daily for weeks. Before after treatment, insulin sensitivity was determined by a two-step hyperinsulinemic euglycemic clamp...

10.1038/s41424-018-0025-4 article EN cc-by-nc-nd Clinical and Translational Gastroenterology 2018-05-01

The hypothalamic neuropeptide orexin influences (feeding) behavior as well energy metabolism. Administration of exogenous orexin-A into the brain has been shown to increase both food intake and blood glucose levels. In present study, we investigated role endogenous release in homeostasis rats.We effects system on basal production (EGP) hepatic peripheral insulin sensitivity by changing orexinergic activity hypothalamus combined with sympathetic or parasympathetic denervation, two-step...

10.2337/db09-0385 article EN cc-by-nc-nd Diabetes 2009-07-10

American children consume up to 27% of calories from high-fat and high-sugar snacks. Both sugar fat consumption have been implicated as a cause hepatic steatosis obesity but the effect meal pattern is largely understudied. We hypothesized that high frequency, compared consuming large meals, detrimental in accumulation intrahepatic abdominal fat. To test this hypothesis, we randomized 36 lean, healthy men 40% hypercaloric diet for 6 weeks or eucaloric control measured triglyceride content...

10.1002/hep.27149 article EN cc-by-nc-nd Hepatology 2014-03-26

Highlights•The presence of hepatic steatosis is associated with insulin resistance•Intrahepatic triglycerides are not sufficient for resistance•Diacylglycerol in cytosol predicts inhibition glucose production•Diacylglycerol-associated resistance characterized by PKCε translocationSummaryHepatic lipid accumulation has been implicated the development resistance, but translational evidence humans limited. We investigated relationship between liver fat and tissue-specific sensitivity 133 obese...

10.1016/j.celrep.2017.05.035 article EN cc-by-nc-nd Cell Reports 2017-06-01
Coming Soon ...